US Broker Ratings

CG Oncology, Inc. (CGON) Stock Analysis: A Biotech Powerhouse with 41.87% Potential Upside

CG Oncology, Inc. (CGON) is making waves in the biotechnology sector, drawing significant attention from investors with its robust pipeline of bladder cancer treatments. Headquartered in..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 48.90% Potential Upside in Healthcare Innovation

Schrödinger, Inc. (NASDAQ: SDGR) stands at the intersection of healthcare and technology, offering compelling prospects for individual investors. With a current market capitalization of $1.24 billion,..

NewAmsterdam Pharma (NAMS) Stock Analysis: Evaluating the 52.72% Potential Upside

NewAmsterdam Pharma Company N.V. (NAMS), a notable player in the biotechnology sector, has captured investor attention with its promising potential upside of 52.72%. This Dutch biopharmaceutical..

GeneDx Holdings Corp. (WGS) Stock Analysis: Navigating a 58% Potential Upside in the Genomics Space

GeneDx Holdings Corp. (NYSE: WGS) stands at the forefront of the healthcare sector’s promising genomics industry, with its specialized focus on genetic testing services. As a..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A 39% Potential Upside in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising player in the biotechnology sector, presents an intriguing opportunity for investors focused on innovative healthcare solutions. With a market..

Select Medical Holdings Corp (SEM) Stock Analysis: Unpacking a 19.79% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM), a significant player in the healthcare sector, has captured investor attention with its robust growth potential and operational footprint across..

Denali Therapeutics Inc. (DNLI)

⚠️ No article content returned.

..

BioCryst Pharmaceuticals, Inc. (BCRX): Investor Outlook with 207% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a notable player in the healthcare sector, is making waves with its promising pipeline and remarkable potential upside. Specializing in the..

Progyny, Inc. (PGNY) Stock Analysis: Unpacking a 24% Upside Potential in the Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY) continues to capture the attention of investors with its innovative approach to fertility and family-building benefits. As a healthcare plans provider specializing..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A 67.91% Potential Upside with Strong Buy Ratings

Kymera Therapeutics, Inc. (NASDAQ: KYMR) has captured investor attention with its innovative approach in the biotechnology sector. This clinical-stage biopharmaceutical company, headquartered in Watertown, Massachusetts, is..

HUTCHMED (China) Limited (HCM): Investor Outlook on a 39.47% Upside in the Growing Oncology Market

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, is making waves in the pharmaceutical industry with its innovative approach to cancer treatment...

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Leader with 26% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is making waves in the biotechnology sector with its robust pipeline and promising valuation metrics. With a market capitalization of $3.8..

Harmony Biosciences Holdings, Inc. (HRMY): Growth Prospects and a 27% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is capturing investor attention with its solid growth trajectory and promising pipeline in the biotechnology sector. With a market capitalization..

Addus HomeCare Corporation (ADUS): Investor Outlook Highlights Strong Growth Potential with 31.16% Upside

Addus HomeCare Corporation (NASDAQ: ADUS) presents a compelling opportunity for investors within the healthcare sector, particularly in the medical care facilities industry. With a market capitalization..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 14.67% Potential Upside in the Healthcare Diagnostics Sector

For investors eyeing opportunities in the healthcare diagnostics sector, Veracyte, Inc. (NASDAQ: VCYT) presents a compelling case. With a market capitalization of $3.29 billion, Veracyte’s innovative..

LeMaitre Vascular, Inc. (LMAT) Stock Report: Analyzing 17.44% Potential Upside with Strong Revenue Growth

LeMaitre Vascular, Inc. (NASDAQ: LMAT) has captured investor attention with its robust presence in the medical instruments and supplies sector. With a market capitalization of $2..

Organon & Co. (OGN) Stock Analysis: Evaluating the 6.82% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Organon & Co. (NYSE: OGN) presents an intriguing prospect. This Jersey City-headquartered company, with a rich..

Disc Medicine, Inc. (IRON) Stock Analysis: A 72% Upside Potential in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON), a promising player in the biotechnology sector, has captured the attention of investors with its strong growth potential and innovative focus..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A 53.56% Potential Upside Beckons Investors

Catalyst Pharmaceuticals, Inc. (CPRX), a prominent player in the biotechnology sector, is capturing investor attention with its significant potential upside of 53.56%. The company, which focuses..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 53.88% Potential Upside

Ardent Health, Inc. (NASDAQ: ARDT), a prominent player in the healthcare sector, continues to captivate investor attention with its robust network of hospitals and clinics across..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds